Drugplain

Nicotine Transdermal System step 2 14 mg/24h

Nicotine · PATCH, EXTENDED RELEASE · CARDINAL HEALTH 110, LLC. DBA LEADER

No Recall History
Plain English

Nicotine Transdermal System step 2 is a patch, extended release containing nicotine at 14 mg/24h, taken transdermal. Manufactured by CARDINAL HEALTH 110, LLC. DBA LEADER.

Key Facts

Brand Name
Nicotine Transdermal System step 2
Generic Name
Nicotine
NDC Code (Product)
70000-0761
Manufacturer
CARDINAL HEALTH 110, LLC. DBA LEADER
Strength
14 mg/24h
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Marketing Status
Application #
NDA020076
Drug Class
Cholinergic Nicotinic Agonist [EPC]
Marketing Start
03/20/2026

Recall History

No Recall History

Frequently Asked Questions

What is Nicotine Transdermal System step 2 used for?

Nicotine Transdermal System step 2 contains Nicotine. It is a patch, extended release taken transdermal. Consult your doctor for specific uses.

Is Nicotine Transdermal System step 2 a controlled substance?

Nicotine Transdermal System step 2 is not classified as a controlled substance by the DEA.

What is the generic name for Nicotine Transdermal System step 2?

The generic name for Nicotine Transdermal System step 2 is Nicotine. There are 12 other brand versions of Nicotine.

What is the NDC code for Nicotine Transdermal System step 2 14 mg/24h?

The NDC (National Drug Code) for Nicotine Transdermal System step 2 14 mg/24h is 70000-0761, listed by CARDINAL HEALTH 110, LLC. DBA LEADER.